Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)

NCT02903355 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

351

Enrollment

OTHER

Sponsor class

Conditions

Noise-induced Hearing Loss

Interventions

DRUG: D-methionine
DRUG: Placebo

Sponsor

Southern Illinois University